Geneticists have plans to build synthetic human genome: Here’s what you need to know

The GLP aggregated and excerpted this blog/article to reflect the diversity of news, opinion and analysis.

The biggest beneficiary of a plan to fabricate a human genome from scratch could be a Massachusetts startup called Gen9 that has close ties to the authors of the still-secretive proposal.

Recently, more than 130 scientists, ethicists, and government funding officials met behind closed doors at Harvard University to discuss a follow-up to the Human Genome Project—one that would write a genome rather than read it. The event, named HGP Write, was meant to rally interest around the idea of synthesizing all six billion DNA letters of a human genome and using the results to “boot up” a cell.

Related on the SLP

Plastic surgeons group rejects gender-transitioning plastic surgery for youth 18 or younger Limiting gender affirming interventions: Trump administration targets Texas even though it already bans youth access

Ahead of the midterms, Meta has paid at least 29 anti-LGBTQ accounts for their posts

Viewpoint: RFK Jr.’s stacked FDA advisory council endorses multicancer screening test from ethically- questionable company that would increase false positives and waste billions of dollars

Viewpoint: The price Americans pay for science denialism

That grand goal will require new technology as well as lots and lots of DNA. “We are going to be one of the companies that is going to make this possible,” says Kevin Munnelly, the CEO of Gen9, which was started in 2009 to manufacture DNA strands and whose founders include George Church, the visionary Harvard Medical School geneticist at the center of the genome-writing plans.

Read full, original post: Big Ideas, Big Conflicts in Plan to Synthesize a Human Genome